tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Advertisement

SAB Biotherapeutics (SABS) Revenue

Compare
179 Followers

SAB Biotherapeutics Revenue

SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 114.70K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, SAB Biotherapeutics had annual revenue of 1.32M with -40.94% growth.
Revenue (ttm)
114.70K
Revenue Growth
-92.42%
P/S Ratio
25.59
Revenue/Employee
$20,991
Employees
63
Market Cap
$33.84M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.32M-916.59K+59.06%
Dec 31, 2023
2.24M-21.66M+9.37%
Dec 31, 2022
23.90M-36.97M+39.27%
Dec 31, 2021
60.88M5.64M+110.21%
Dec 31, 2020
55.24M51.80M+1,604.82%
Dec 31, 2019
3.44M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis